UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial

Journal of clinical oncology, 2018-08, Vol.36 (24), p.2514-2523

2018

Link zum Volltext

Verfügbarkeit prüfen

Equal access to innovative therapies and precision cancer care

Nature reviews. Clinical oncology, 2016-06, Vol.13 (6), p.385-393

2016

Link zum Volltext

Verfügbarkeit prüfen

Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy

The Journal of immunology (1950), 2005-06, Vol.174 (12), p.8210-8218

2005

Link zum Volltext

Verfügbarkeit prüfen

IFN Regulatory Factor-2 Cooperates with STAT1 to Regulate Transporter Associated with Antigen Processing-1 Promoter Activity

The Journal of immunology (1950), 2005-04, Vol.174 (7), p.3948-3958

2005

Link zum Volltext

Verfügbarkeit prüfen

Une approche intégrée au service de la lutte contre les cancers

Bulletin du cancer, 2013-06, Vol.100 (6), p.537-540

Buzyn, Agnès

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of Complement System Activation After Allogeneic Hematopoietic Stem Cell Transplantation

Blood, 2009-11, Vol.114 (22), p.1166-1166

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of Donor-Derived Invariant Natural Killer T (iNKT) Cell Reconstitution After Allogeneic Haematopoietic Stem Cell Transplantation

Blood, 2009-11, Vol.114 (22), p.346-346

2009

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology and Risk Factors for Gram-Positive Coccal Infections in Neutropenia: Toward a More Targeted Antibiotic Strategy

Clinical infectious diseases, 2003-01, Vol.36 (2), p.149-158

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM)

Blood, 2010-11, Vol.116 (21), p.3378-3378

2010

Link zum Volltext

Verfügbarkeit prüfen

Complement System Activation after Allogeneic Bone Marrow Transplantation May Early Predict the Development of Acute Gastrointestinal GVHD

Blood, 2007-11, Vol.110 (11), p.2186-2186

2007

Link zum Volltext

Verfügbarkeit prüfen

Waiting times for cancer care in four most frequent cancers in several French regions in 2011 and 2012

Bulletin du cancer, 2013-12, Vol.100 (12), p.1237

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcome of Patients with T-Cell Lymphoblastic Leukemia or Lymphoma: The GRAALL Experience

Blood, 2007-11, Vol.110 (11), p.2818-2818

2007

Link zum Volltext

Verfügbarkeit prüfen

Membrane-Bound Fas (Apo-1/CD95) Ligand on Leukemic Cells: A Mechanism of Tumor Immune Escape in Leukemia Patients

Blood, 1999-11, Vol.94 (9), p.3135-3140

1999

Link zum Volltext

Verfügbarkeit prüfen

Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host disease

Transplantation, 2008-03, Vol.85 (6), p.911

2008

Link zum Volltext

Verfügbarkeit prüfen

Aging and cancer care in France: hospitalization requirement in 2012

Bulletin du cancer, 2015-02, Vol.102 (2), p.139

2015

Link zum Volltext

Verfügbarkeit prüfen

Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response

Cancer Immunology, Immunotherapy, 2009-10, Vol.58 (10), p.1669-1677

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 110

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library - AutoHoldings Journals

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(20)
Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Biological And Medical Sciences
(10)
Medical Sciences
(9)
Female
(8)
Oncology
(8)
Immunology
(7)
Middle Aged
(7)
Sciences Biologiques Et Medicales
(7)
Sciences Medicales
(7)
Hematologic And Hematopoietic Diseases
(6)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(5)
Aged
(4)
Cancer
(4)
Hematology
(4)
Life Sciences
(4)
Male
(4)
Neoplasms - Therapy
(4)
Anticancéreux
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial

Equal access to innovative therapies and precision cancer care

Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy

IFN Regulatory Factor-2 Cooperates with STAT1 to Regulate Transporter Associated with Antigen Processing-1 Promoter Activity

Towards a Purely Oncogenetic Risk Classification of Adult T-ALL: a GRAALL Study

Une approche intégrée au service de la lutte contre les cancers

Minimal Residual Disease At 3 Months, Combined to the Presence of IKZF1 Deletion in B-Lineage or Absence of NOTCH1 pathway Mutation in T-Lineage, Recapitulates the Disease Risk Assessment in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia - A GRAALL Study

Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT

Allogeneic Stem Cell Transplantation (allo-SCT) for Isolated and Leukemic Myeloid Sarcoma (GS): a Survey on Behalf of the Acute Leukemia Working Party (ALWP) of EBMT

Prognostic Significance of Complement System Activation After Allogeneic Hematopoietic Stem Cell Transplantation

Impact of Donor-Derived Invariant Natural Killer T (iNKT) Cell Reconstitution After Allogeneic Haematopoietic Stem Cell Transplantation

Epidemiology and Risk Factors for Gram-Positive Coccal Infections in Neutropenia: Toward a More Targeted Antibiotic Strategy

Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM)

Complement System Activation after Allogeneic Bone Marrow Transplantation May Early Predict the Development of Acute Gastrointestinal GVHD

Prognostic Significance of CD20 Expression in Adult B-Cell Precursor Acute Lymphoblastic Leukemia

Waiting times for cancer care in four most frequent cancers in several French regions in 2011 and 2012

Outcome of Patients with T-Cell Lymphoblastic Leukemia or Lymphoma: The GRAALL Experience

Results of the AFR07 Prospective Study in De Novo Philadelphia Positive ALL Patients Aged over 55 Years: Efficacy and Safety of a Glivec® Based Induction Followed by Maintenance Therapy with Glivec® and Pegasys

Membrane-Bound Fas (Apo-1/CD95) Ligand on Leukemic Cells: A Mechanism of Tumor Immune Escape in Leukemia Patients

Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host disease

Atypical BCR-ABL Transcripts Chronic Myelogenous Leukemias Show Particular Features, and Their Classical Worse Prognosis Seems Abrogated by Imatinib Mesylate. A Retrospective Analysis of 22 Patients, on the Behalf of the French Intergroup of CML (Fi(ϕ)-LMC Group)

Aging and cancer care in France: hospitalization requirement in 2012

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly with Imatinib Mesylate (STI571) and Chemotherapy

Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response

The Upper Age Limit for a Pediatric-Inspired Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL)? Analysis of the Graall-2005 Study

Aktive Filter

Suchergebnisse filtern